Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
October 4, 2004
- CORPORATE ROUNDUP NEWS IN BRIEF
October 4, 2004
- GVP, GQP GLs Promulgated
October 4, 2004
- Korosho, Monkasho Hold Hearings on Promotion of Clinical Trials
October 4, 2004
- Only 6.9% of Medical Bills Processed Electronically
October 4, 2004
- GL for Treatment of Myasthenia Gravis Compiled
October 4, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 4, 2004
- IMSUT Embarks on Clinical Study to Predict Iressa's Effects
October 4, 2004
- PRESS SEMINAR
October 4, 2004
- ZLB Behring to Expand Plasma Fraction Business in Japan: Mr Strenger
October 4, 2004
- OTC NEWS IN BRIEF
October 4, 2004
- Itochu Sees Contract Drug Distribution as Growth Opportunity
October 4, 2004
- Olympus to Beef Up Biomaterials, Tissue Engineering Business
October 4, 2004
- MediciNova to Step Forward in Global Drug Development, Commercialization
October 4, 2004
- Iryo Proverbs Reveal Japanese Spirit (23)
October 4, 2004
- Booklet on MRs' Roles to Be Thoroughly Revised
October 4, 2004
- Pip-Tokyo, Alfresa to Set Up SPD/Medical Materials JV House
October 4, 2004
- MEDICAL DEVICE NEWS IN BRIEF
September 27, 2004
- DIAGNOSTIC NEWS IN BRIEF
September 27, 2004
- WORLD NEWS IN BRIEF
September 27, 2004
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…